Olink Bioscience and PioneerBiomed sign distributorship agreement for the Chinese market.
UPPSALA, SWEDEN, March 4, 2010 – Olink Bioscience has signed a distributorship agreement with Beijing Pioneer Medical Instrument Co., Ltd for distribution of the Duolink® product line in China.
“We are proud to announce the collaboration with this highly respected company” says Peter Karlberg, Director of Sales and Marketing at Olink Bioscience and continues “this agreement represents a huge commercial opportunity for Olink Bioscience and we are confident that this will bring us valuable new business both in the academic and the biotech/pharmaceutical industry throughout the country”.
“The Duolink regent kit based on PLA® technology is exactly the kind of product PioneerBiomed is looking for that meet our customers demands for new and innovative research products” says Jason Zhihuan Wang, President and CEO of PioneerBiomed.
The Duolink product line is based on Olink Bioscience proprietary in situ PLA, a proximity ligation assay technology that extends the capabilities of traditional protein techniques to include direct detection of proteins, protein interactions and modifications with unparalleled specificity and sensitivity. Target proteins are detected with single molecule resolution, allowing digital quantification and information about the exact localization of the target. Furthermore, the proteins can be studied at normal expression levels in fixed cells and tissue sections.
About Olink Bioscience
Olink Bioscience is a privately held biotech supply company based in Uppsala, Sweden founded in 2004. The company controls significant IP covering technologies related to detection and analysis of proteins and nucleic acids. These technologies are commercialized as proprietary Olink Bioscience products, in spin-out companies and in collaboration with external organization. In 2007 Olink Bioscience introduced the Duolink product line for in situ detection of proteins, protein interactions and protein modifications. These products are based on PLA, a proximity ligation assays technology which use dual recognition of the analyte in combination with a DNA amplification based reporter system, resulting in unparalleled sensitivity and specificity. The technology is available as reagent kits and contract research projects through Olink Bioscience.
Duolink is intended for research use only. Duolink is not for use in human diagnostic or therapeutic procedures.
About Beijing Pioneer Medical Instruments Co., Ltd
PioneerBiomed, founded in 1997, is a leading distributor of imported biological and medical devices, reagents, and consumables in the biomedical industry with a large customer base. Headquartered in Beijing, PioneerBiomed employs 69 management, sales, technical, and administrative professionals. As one of the fastest growing companies in China, PioneerBiomed has been dedicated to provide its customers with high-quality products and services, and the newest technologies. The company’s customers include academic, clinical, government, and biotech/pharmaceutical facilities throughout the country.
For information please contact:
Peter Karlberg
Director Sales and Marketing
Olink Bioscience
Phone: +46 (0)18 444 30 70
Email: peter.karlberg@olink.com
Jason Zhihuan Wang
President and CEO
Beijing Pioneer Medical Instrument Co., Ltd
Phone: 86-10-85746011/12/13/14/15/16/17/18
Email: zhihuanw@yahoo.com
Pressmeddelandet skickades med MyNewsdesk